Šalis: Naujoji Zelandija
kalba: anglų
Šaltinis: Medsafe (Medicines Safety Authority)
Amoxicillin trihydrate 294.118mg equivalent to amoxycillin 250 mg; Amoxicillin trihydrate 292.4mg equivalent to amoxycillin 250 mg
GlaxoSmithKline NZ Limited
Amoxicillin trihydrate 294.118 mg (equivalent to amoxycillin 250 mg)
250 mg
Capsule
Active: Amoxicillin trihydrate 294.118mg equivalent to amoxycillin 250 mg Excipient: Gelatin Iron oxide red Iron oxide yellow Magnesium stearate Titanium dioxide Active: Amoxicillin trihydrate 292.4mg equivalent to amoxycillin 250 mg Excipient: Erythrosine Gelatin Indigo carmine Iron oxide yellow Magnesium stearate Titanium dioxide
Blister pack, PVC/Al, 20 capsules
Prescription
Prescription
Beecham Pharmaceuticals (PTE) Ltd
For the treatment of infections due to susceptible organisms.
Package - Contents - Shelf Life: Blister pack, PVC/Al - 20 capsules - 24 months from date of manufacture stored at or below 25°C - Blister pack, PVC/Al - 100 capsules - 24 months from date of manufacture stored at or below 25°C - Bottle, plastic, - 100 capsules - 60 months from date of manufacture stored at or below 25°C - Bottle, plastic, - 500 capsules - 60 months from date of manufacture stored at or below 25°C
1972-10-18
1 NEW ZEALAND DATA SHEET AMOXIL ® _AMOXYCILLIN TRIHYDRATE _ PRESENTATION AMOXIL Paediatric Drops: Fruit flavoured suspension providing 125mg amoxycillin per 1.25mL (measured by the pipette supplied). Presented as powder in bottles for preparing 20mL. AMOXIL Syrups: Fruit flavoured sugar free syrup providing 125mg or 250mg amoxycillin per 5mL. Presented as powder in bottles for preparing 100mL. AMOXIL Capsules 250mg: hard gelatine capsule containing 250mg amoxycillin with red opaque cap/yellow opaque body, marked GS LEX in white ink filled with white granular powder. Packs of 20 or 100. AMOXIL Capsules 500mg: hard gelatine capsule containing 500mg amoxycillin with red opaque cap/yellow opaque body, marked GS JVL in white ink filled with white granular powder. Packs of 20 or 100. INDICATIONS AMOXIL should be used in accordance with local antibiotic-prescribing information guidelines and local susceptibility data. Treatment of Infection: AMOXIL is indicated in the treatment of infections due to susceptible organisms. AMOXIL may be useful in instituting therapy prior to bacteriology; however bacteriological studies to determine the causative organisms and their sensitivity to AMOXIL should be performed. Prophylaxis for endocarditis: AMOXIL may be used for the prevention of bacteraemia, associated with procedures such as dental extraction, in patients at risk of developing bacterial endocarditis. Susceptibility to amoxicillin will vary with geography and time and local susceptibility data should be consulted where available and microbiological sampling and susceptibility testing performed where necessary (see Further Information, Pharmacodynamic properties). 2 DOSAGE AND ADMINISTRATION UPPER RESPIRATORY TRACT INFECTIONS (DUE TO STREPTOCOCCI, PNEUMOCOCCI, NON Perskaitykite visą dokumentą